THE PENNANT GROUP, INC. Operating Lease, Payments
THE PENNANT GROUP, INC. (PNTG) reported Operating Lease, Payments of $23.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-05
- THE PENNANT GROUP, INC. operating lease, payments for the quarter ending 2026-06-30 was $11.98M, a 10.83% increase year-over-year.
- THE PENNANT GROUP, INC. operating lease, payments for the quarter ending 2026-03-31 was $11.71M, a 9.57% increase year-over-year.
- THE PENNANT GROUP, INC. operating lease, payments for the quarter ending 2025-12-31 was $11.69M, a 13.80% increase year-over-year.
- THE PENNANT GROUP, INC. operating lease, payments for the quarter ending 2025-09-30 was $10.82M, a 8.33% increase year-over-year.
- THE PENNANT GROUP, INC. operating lease, payments for fiscal 2025 was $44.00M, a 11.39% increase from fiscal 2024.
- THE PENNANT GROUP, INC. operating lease, payments for fiscal 2024 was $39.50M, a 7.78% increase from fiscal 2023.
- THE PENNANT GROUP, INC. operating lease, payments for fiscal 2023 was $36.65M, a 1.83% increase from fiscal 2022.
- THE PENNANT GROUP, INC. operating lease, payments for fiscal 2022 was $35.99M, a 8.06% decline from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $23.69M 10-Q · filed 2026-08-05 | $35.38M derived: sum of 3 quarters · filed 2026-08-05 | $46.19M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $11.71M 10-Q · filed 2026-05-06 | $23.40M derived: sum of 2 quarters · filed 2026-05-06 | $34.22M derived: sum of 3 quarters · filed 2026-05-06 | $45.02M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $11.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $22.50M derived: sum of 2 quarters · filed 2026-02-26 | $33.31M derived: sum of 3 quarters · filed 2026-08-05 | $44.00M 10-K · filed 2026-02-26 |
| 2025-09-30 | $10.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $21.62M derived: sum of 2 quarters · filed 2026-08-05 | $32.31M 10-Q · filed 2025-11-05 | $42.58M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $10.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $21.50M 10-Q · filed 2026-08-05 | $31.77M derived: sum of 3 quarters · filed 2026-08-05 | $41.75M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $10.69M 10-Q · filed 2026-05-06 | $20.96M derived: sum of 2 quarters · filed 2026-05-06 | $30.95M derived: sum of 3 quarters · filed 2026-05-06 | $40.72M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $10.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $20.25M derived: sum of 2 quarters · filed 2026-02-26 | $30.03M derived: sum of 3 quarters · filed 2026-02-26 | $39.50M 10-K · filed 2026-02-26 |
| 2024-09-30 | $9.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $19.76M derived: sum of 2 quarters · filed 2025-11-05 | $29.23M 10-Q · filed 2025-11-05 | $38.65M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $9.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $19.25M 10-Q · filed 2025-08-06 | $28.67M derived: sum of 3 quarters · filed 2026-02-26 | $38.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $9.47M 10-Q · filed 2025-05-06 | $18.89M derived: sum of 2 quarters · filed 2026-02-26 | $28.23M derived: sum of 3 quarters · filed 2026-02-26 | $37.20M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $9.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $18.75M derived: sum of 2 quarters · filed 2026-02-26 | $27.73M derived: sum of 3 quarters · filed 2026-02-26 | $36.65M 10-K · filed 2026-02-26 |
| 2023-09-30 | $9.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $18.30M derived: sum of 2 quarters · filed 2024-11-06 | $27.23M 10-Q · filed 2024-11-06 | $36.13M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $8.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $17.90M 10-Q · filed 2024-08-06 | $26.80M derived: sum of 3 quarters · filed 2025-02-27 | $35.64M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $8.93M 10-Q · filed 2024-05-06 | $17.83M derived: sum of 2 quarters · filed 2025-02-27 | $26.66M derived: sum of 3 quarters · filed 2025-02-27 | $35.41M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $17.74M derived: sum of 2 quarters · filed 2025-02-27 | $26.48M derived: sum of 3 quarters · filed 2025-02-27 | $35.99M 10-K · filed 2025-02-27 |
| 2022-09-30 | $8.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $17.58M derived: sum of 2 quarters · filed 2023-11-07 | $27.09M 10-Q · filed 2023-11-07 | $36.92M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $8.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $18.26M 10-Q · filed 2023-08-08 | $28.08M derived: sum of 3 quarters · filed 2024-02-28 | $37.91M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $9.52M 10-Q · filed 2023-05-04 | $19.34M derived: sum of 2 quarters · filed 2024-02-28 | $29.17M derived: sum of 3 quarters · filed 2024-02-28 | $38.95M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $9.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $19.66M derived: sum of 2 quarters · filed 2024-02-28 | $29.44M derived: sum of 3 quarters · filed 2024-02-28 | $39.15M 10-K · filed 2024-02-28 |
| 2021-09-30 | $9.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $19.61M derived: sum of 2 quarters · filed 2022-11-07 | $29.33M 10-Q · filed 2022-11-07 | $36.18M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $9.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $19.50M 10-Q · filed 2022-08-08 | $26.35M derived: sum of 3 quarters · filed 2023-02-23 | $36.89M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $9.71M 10-Q · filed 2022-05-09 | $16.57M derived: sum of 2 quarters · filed 2023-02-23 | $27.10M derived: sum of 3 quarters · filed 2023-02-23 | $37.47M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $6.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $17.39M derived: sum of 2 quarters · filed 2023-02-23 | $27.76M derived: sum of 3 quarters · filed 2023-02-23 | $35.85M 10-K · filed 2023-02-23 |
| 2020-09-30 | $10.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $20.91M derived: sum of 2 quarters · filed 2021-11-08 | $29.00M 10-Q · filed 2021-11-08 | $40.72M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $10.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $18.46M 10-Q · filed 2021-08-09 | $30.18M derived: sum of 3 quarters · filed 2022-02-28 | $38.83M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $8.09M 10-Q · filed 2021-05-06 | $19.81M derived: sum of 2 quarters · filed 2022-02-28 | $28.46M derived: sum of 3 quarters · filed 2022-02-28 | $36.88M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $11.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $20.37M derived: sum of 2 quarters · filed 2022-02-28 | $28.79M derived: sum of 3 quarters · filed 2022-02-28 | $37.09M 10-K · filed 2022-02-28 |
| 2019-09-30 | $8.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $17.07M derived: sum of 2 quarters · filed 2020-11-10 | $25.37M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $8.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $16.72M 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $8.30M 10-Q · filed 2020-05-13 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |